Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Total Current Liabilities (2023 - 2026)

Adagio Medical Holdings has reported Total Current Liabilities over the past 4 years, most recently at $8.6 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 42.74% to $8.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.6 million through Mar 2026, up 42.74% year-over-year, with the annual reading at $8.2 million for FY2025, 6.05% up from the prior year.
  • Total Current Liabilities was $8.6 million for Q1 2026 at Adagio Medical Holdings, up from $8.2 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $47.2 million in Q4 2023 and troughed at $4.9 million in Q2 2025.
  • The 4-year median for Total Current Liabilities is $8.1 million (2024), against an average of $12.5 million.
  • Year-over-year, Total Current Liabilities tumbled 83.54% in 2024 and then soared 42.74% in 2026.
  • A 4-year view of Total Current Liabilities shows it stood at $47.2 million in 2023, then tumbled by 83.54% to $7.8 million in 2024, then increased by 6.05% to $8.2 million in 2025, then rose by 4.13% to $8.6 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Total Current Liabilities are $8.6 million (Q1 2026), $8.2 million (Q4 2025), and $9.7 million (Q3 2025).